Ranibizumab: The First Vascular Endothelial Growth Factor Inhibitor Approved for the Treatment of Diabetic Macular Edema
Author:
Affiliation:
1. Kirk E Evoy, PharmD Student, College of Pharmacy, Purdue University, West Lafayette, IN
2. Steven R Abel PharmD, Bucke Professor of Pharmacy Practice, College of Pharmacy, Purdue University
Abstract
Publisher
SAGE Publications
Subject
Pharmacology (medical)
Link
http://journals.sagepub.com/doi/pdf/10.1345/aph.1S013
Reference26 articles.
1. Ranibizumab
2. Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
3. Anti–Vascular Endothelial Growth Factor Pharmacotherapy for Diabetic Macular Edema
4. Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)
5. Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Aflibercept versus ranibizumab for diabetic macular edema: A meta-analysis;European Journal of Ophthalmology;2023-05-24
2. Cardiovascular and Cerebrovascular Safety of Ranibizumab, Bevacizumab, and Aflibercept in Ocular Diseases: An Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) Database;The Journal of Clinical Pharmacology;2023-05-23
3. Diabetic retinopathy in the pediatric population: Pathophysiology, screening, current and future treatments;Pharmacological Research;2023-02
4. Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective;Frontiers in Immunology;2022-08-23
5. Effect of intravitreal injection of ranibizumab on retinal ganglion cells and microvessels in the early stage of diabetic retinopathy in rats with streptozotocin-induced diabetes;Experimental and Therapeutic Medicine;2017-05-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3